Stock comparison
Amgen
AMGN
Market cap
$188.67B
Sector
Healthcare
Overall winner
IDEXX Laboratories
AMGN 1–5 IDXX
IDEXX Laboratories
IDXX
Market cap
$44.34B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AMGNvsIDXX
63C
75B
81A
81A
63C
76B
73B
71B
48D
83C
72B
87A
67D
84A
Side-by-side metrics
| Metric | AMGN | IDXX |
|---|---|---|
| Market cap | $188.67B | $44.34B |
| P/E (TTM) | 23.3x | 40.3x |
| EV/EBIT | 21.3x | 32.6x |
| ROIC (TTM) | 13.85% | 40.66% |
| Gross margin | 71.46% | 62.05% |
| Net margin | 20.95% | 24.63% |
| Revenue CAGR 5y | 9.05% | 7.56% |
| EPS CAGR 5y | 8.5% | 10.79% |
| Debt / Equity | 6.2x | 0.7x |
| Dividend yield | 2.91% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AMGN leads on
- Dividend yield2.91%vs 0.0%+100%
- Market cap$188.67Bvs $44.34B+76%
- P/E (TTM)23.3xvs 40.3x+42%
- EV/EBIT21.3xvs 32.6x+35%
IDXX leads on
- Debt / Equity0.7xvs 6.2x+89%
- ROIC (TTM)40.66%vs 13.85%+66%
- EPS CAGR 5y10.79%vs 8.5%+21%
- Net margin24.63%vs 20.95%+15%
More like AMGN
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.